Considering the reduction in epithelial cells, E-cadherin was poorly expressed in glioma, so we tested the expression of vimentin and N-cadherin to analyze the EMT process in glioma (Liu et al., 2019). The gene discussed is CDH1; the disease is central nervous system cancer.